scholarly journals Disease Classification from ECG Signal Using R-Peak Analysis with Artificial Intelligence

Author(s):  
Pooja Sharma ◽  
D.V Gupta
2009 ◽  
Vol 34 (5) ◽  
pp. 815-828 ◽  
Author(s):  
Abdurrahim Akgundogdu ◽  
Rachid Jennane ◽  
Gabriel Aufort ◽  
Claude Laurent Benhamou ◽  
Osman Nuri Ucan

2022 ◽  
pp. 80-127
Author(s):  
Viswanathan Rajagopalan ◽  
Houwei Cao

Despite significant advancements in diagnosis and disease management, cardiovascular (CV) disorders remain the No. 1 killer both in the United States and across the world, and innovative and transformative technologies such as artificial intelligence (AI) are increasingly employed in CV medicine. In this chapter, the authors introduce different AI and machine learning (ML) tools including support vector machine (SVM), gradient boosting machine (GBM), and deep learning models (DL), and their applicability to advance CV diagnosis and disease classification, and risk prediction and patient management. The applications include, but are not limited to, electrocardiogram, imaging, genomics, and drug research in different CV pathologies such as myocardial infarction (heart attack), heart failure, congenital heart disease, arrhythmias, valvular abnormalities, etc.


2019 ◽  
Vol 7 (4) ◽  
pp. 208-213 ◽  
Author(s):  
Fabian V. Filipp

Abstract Purpose of Review We critically evaluate the future potential of machine learning (ML), deep learning (DL), and artificial intelligence (AI) in precision medicine. The goal of this work is to show progress in ML in digital health, to exemplify future needs and trends, and to identify any essential prerequisites of AI and ML for precision health. Recent Findings High-throughput technologies are delivering growing volumes of biomedical data, such as large-scale genome-wide sequencing assays; libraries of medical images; or drug perturbation screens of healthy, developing, and diseased tissue. Multi-omics data in biomedicine is deep and complex, offering an opportunity for data-driven insights and automated disease classification. Learning from these data will open our understanding and definition of healthy baselines and disease signatures. State-of-the-art applications of deep neural networks include digital image recognition, single-cell clustering, and virtual drug screens, demonstrating breadths and power of ML in biomedicine. Summary Significantly, AI and systems biology have embraced big data challenges and may enable novel biotechnology-derived therapies to facilitate the implementation of precision medicine approaches.


2021 ◽  
Vol 36 (1) ◽  
pp. 443-450
Author(s):  
Mounika Jammula

As of 2020, the total area planted with crops in India overtook 125.78 million hectares. India is the second biggest organic product maker in the world. Thus, an Indian economy greatly depends on farming products. Nowadays, farmers suffer a drop in production due to a lot of diseases and pests. Thus, to overcome this problem, this article presents the artificial intelligence based deep learning approach for plant disease classification. Initially, the adaptive mean bilateral filter (AMBF) for noise removal and enhancement operations. Then, Gaussian kernel fuzzy C-means (GKFCM) approach is used to segment the effected disease regions. The optimal features from color, texture and shape features are extracted by using GLCM. Finally, Deep learning convolutional neural network (DLCNN) is used for the classification of five class diseases. The segmentation and classification performance of proposed method outperforms as compared with the state of art approaches.


2021 ◽  
pp. flgastro-2021-102003
Author(s):  
Johanne Brooks-Warburton ◽  
James Ashton ◽  
Anjan Dhar ◽  
Tony Tham ◽  
Patrick B Allen ◽  
...  

Artificial intelligence (AI) is an emerging technology predicted to have significant applications in healthcare. This review highlights AI applications that impact the patient journey in inflammatory bowel disease (IBD), from genomics to endoscopic applications in disease classification, stratification and self-monitoring to risk stratification for personalised management. We discuss the practical AI applications currently in use while giving a balanced view of concerns and pitfalls and look to the future with the potential of where AI can provide significant value to the care of the patient with IBD.


Sign in / Sign up

Export Citation Format

Share Document